Acorda Therapeutics (26) | Human Resources (12)

Browse by Subcategory

Recent Contracts

Separation Agreement and General Release dated December 31, 2021, by and between the Registrant and Burkhard Blank, M.D (Filed With SEC on March 18, 2022)
Amendment dated January 6, 2022, to June 8, 2015 Employment Agreement by and between the Registrant and Lauren Sabella (Filed With SEC on March 18, 2022)
Master Consulting Agreement, dated as of January 1, 2022, and Schedule #1 under the Master Consulting Agreement, by and between the Registrant and Burkhard Blank, M.D (Filed With SEC on March 18, 2022)
Form of time-based vesting Restricted Stock Unit Agreement for awards under the Acorda Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan (Filed With SEC on May 12, 2021)
Severance policies applicable to Robert Morales, Vice President, Finance and Controller, and interim principal financial and accounting officer (Filed With SEC on May 12, 2021)
Acorda Therapeutics, Inc. Directors Compensation Policy, as amended April 15, 2021 (Filed With SEC on May 12, 2021)
Employment offer letter, dated November 4, 2021, by and between the Registrant and Michael Gesser (Filed With SEC on March 18, 2022)
Employment offer letter, dated November 4, 2021, by and between the Registrant and Neil Belloff (Filed With SEC on March 18, 2022)
Employment Agreement dated September 1, 2020, by and between the Company and Kerry Clem (Filed With SEC on September 9, 2021)
Consulting Agreement, dated November 11, 2019, by and between the Registrant and Jane Wasman (Filed With SEC on February 28, 2020)
Amendment to December 19, 2005 Employment Agreement, dated August 13, 2019, by and between the Registrant and David Lawrence (Filed With SEC on November 7, 2019)
Amendment to December 19, 2005 Employment Agreement, dated August 13, 2019, by and between the Registrant and Jane Wasman (Filed With SEC on November 7, 2019)